Biotech · Private company
ObsEva SA
Track this companyFree. Adds ObsEva SA to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Add-backPhase 3 · Uterine FibroidsClinicalTrials.gov · fetched Nov 12, 2026
- OBE2109Phase 3 · Uterine FibroidsClinicalTrials.gov · fetched Nov 12, 2026
- OBE2109Phase 2 · EndometriosisClinicalTrials.gov · fetched Nov 12, 2026
- LinzagolixPhase 1 · Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- LinzagolixPhase 1 · Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal FunctionPHASE1 · COMPLETED · started May 15, 2019ClinicalTrials.gov NCT03961932 · fetched Nov 12, 2026
- Safety and Pharmacokinetics Study of Linzagolix in Female Subjects With Normal and Impaired Hepatic FunctionPHASE1 · COMPLETED · started May 15, 2019ClinicalTrials.gov NCT03962049 · fetched Nov 12, 2026
- Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine FibroidsPHASE3 · COMPLETED · started May 23, 2017ClinicalTrials.gov NCT03070951 · fetched Nov 12, 2026
- Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine FibroidsPHASE3 · COMPLETED · started Apr 20, 2017ClinicalTrials.gov NCT03070899 · fetched Nov 12, 2026
- A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With EndometriosisPHASE2 · COMPLETED · started Jul 1, 2016ClinicalTrials.gov NCT02778399 · fetched Nov 12, 2026